PacBio (Revio sequencing system) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

PacBio (Revio sequencing system) General Information

Description

A biotechnology sequencing system. The sequencing system provides small variants, structural variants, repeat expansions, methylation, and haplotype phasing from a single library and sequencing run.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Menlo Park, CA
  • United States
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Acquirer
MedGenome Labs
Corporate Office
  • Menlo Park, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PacBio (Revio sequencing system) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PacBio (Revio sequencing system)‘s full profile, request access.

Request a free trial

PacBio (Revio sequencing system) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PacBio (Revio sequencing system)‘s full profile, request access.

Request a free trial

PacBio (Revio sequencing system) FAQs

  • Where is PacBio (Revio sequencing system) headquartered?

    PacBio (Revio sequencing system) is headquartered in Menlo Park, CA.

  • What industry is PacBio (Revio sequencing system) in?

    PacBio (Revio sequencing system)’s primary industry is Buildings and Property.

  • Is PacBio (Revio sequencing system) a private or public company?

    PacBio (Revio sequencing system) is a Private company.

  • What is PacBio (Revio sequencing system)’s current revenue?

    The current revenue for PacBio (Revio sequencing system) is .

  • Who are PacBio (Revio sequencing system)’s investors?

    Pacific BioSciences of California has invested in PacBio (Revio sequencing system).

  • When was PacBio (Revio sequencing system) acquired?

    PacBio (Revio sequencing system) was acquired on 18-Jul-2024.

  • Who acquired PacBio (Revio sequencing system)?

    PacBio (Revio sequencing system) was acquired by MedGenome Labs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process